Oscar Health, Inc. (OSCR) vs Praxis Precision Medicines, Inc. (PRAX)

A side-by-side comparison of Oscar Health, Inc. and Praxis Precision Medicines, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — OSCR vs PRAX

growth of $100 · dividends reinvested · last 6y
OSCR -6.8% (-1.2%/yr)PRAX -49.0% (-10.6%/yr)OSCR compounded faster over this window
050100Start $10020222023202420252026$93$51
OSCR PRAX

OSCR vs PRAX: by the numbers

  • •OSCR is the larger company ($8.40B vs $7.63B market cap).
  • •OSCR is profitable (3.60% net margin) while PRAX runs a net loss (0.00%).

Metrics side by side

Valuation

MetricOSCRPRAX
P/E ratio23.14N/A
Forward P/E16.97N/A
P/S ratio0.55N/A
P/B ratio4.095.69
EV / EBITDA7.29N/A
FCF yield51.60%N/A

Profitability

MetricOSCRPRAX
Gross margin14.38%0.00%
Operating margin4.07%0.00%
Net margin3.60%0.00%
ROE26.84%-25.29%
ROIC22.98%-28.18%

Growth (annualized)

MetricOSCRPRAX
Revenue CAGR (5Y)64.83%N/A
FCF CAGR (5Y)80.81%N/A
Total return CAGR (5Y)14.97%-0.21%

Frequently asked

Is OSCR or PRAX more profitable?
OSCR runs the higher net margin — OSCR at 3.60% versus PRAX at 0.00%.
How have OSCR and PRAX total returns compared?
Over the past 5 years, OSCR delivered 14.97% and PRAX delivered -0.21% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.